Quantcast

Latest Stem cell treatments Stories

2014-05-16 08:27:03

/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr, will present at the World Stem Cells & Regenerative Medicine Congress, on Thursday, May 22, at 11:35 a.m. BST in London, UK (http://www.terrapinn.com/conference/stem-cells/index.stm). Neuralstem is currently in a Phase II clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its NSI-566 stem cells and has been approved to commence a Phase I study in spinal cord...

2014-05-15 23:06:12

Local Stem Cell Clinic Celebrates Anniversary with Hundreds of Patients Treated Tampa, Florida (PRWEB) May 15, 2014 On Tuesday, May 20, Lung Institute is celebrating the first anniversary of its Tampa location. As a leader in regenerative medicine, Lung Institute has provided over 250 treatments to lung disease patients who previously had no hope for better breathing and regaining quality of life. Lung Institute treats lung diseases including pulmonary fibrosis and chronic obstructive...

A Fetal Enzyme Helps Stem Cells Recover From Limb Injuries
2014-05-15 07:41:44

April Flowers for redOrbit.com - Your Universe Online Nearly two million Americans a year suffer from ischemia reperfusion injuries. A wide variety of scenarios can be caused by these injuries that result in restricted blood flow—from traumatic limb injuries, to heart attacks, to donor organs. Restoring the blood flow to an injured leg, for example, seems like it would be a good idea. A new study from Georgia Regents University, however, suggests that restoring the flow could cause...

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-12 08:32:37

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The...

2014-05-09 23:09:06

Tom McManus, former professional football player with Jacksonville Jaguars, is teaming up with SmartChoice® Stem Cell Institute as a spokesperson to promote awareness of benefits and success of Adult Stem Cell procedures as non-surgical treatment for sports injuries, arthritis, joint and back pain. Jacksonville, FL (PRWEB) May 09, 2014 Tom McManus, former professional football player with the Jacksonville Jaguars is teaming up with SmartChoice® Stem Cell Institute as a...

2014-05-08 23:12:39

Dr. Jeffrey Adler and Dr. Darline Kulhan both of Adler Footcare New York will be featured on NewsTalkRadio 77 WABC on May 10 to discuss stem cell replacement therapy and HyProCure, new treatment options available for painful foot problems. New York, NY (PRWEB) May 08, 2014 New York podiatrists Dr. Jeffrey Adler and Dr. Darline Kulhan, will be interviewed by radio personality Laura Smith on New York talk show 77 WABC about the use of stem cells and a procedure called HyProCure, both used...

2014-05-08 12:29:52

SALT LAKE CITY, May 8, 2014 /PRNewswire-USNewswire/ -- Mice severely disabled by a multiple sclerosis (MS) - like condition could walk less than two weeks following treatment with human stem cells. The finding, which uncovers new avenues for treating MS, will be published online on May 15, 2014, in the journal Stem Cell Reports. http://photos.prnewswire.com/prnvar/20140205/DC59634LOGO When scientists transplanted human stem cells into MS mice, they predicted the cells would be...

2014-05-08 08:34:19

ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced the appointment of Sandford Drexel Smith to its Board of Directors, bringing the total number of board members to seven, five of whom are independent. Mr. Smith is the former President, International Group, and Executive Vice President of Genzyme Corporation. He also served on Genzyme's Executive Committee, where he reported directly to the Chairman and CEO. As President of the International Group,...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related